Compare VRCA & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRCA | ZVIA |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.3M | 111.3M |
| IPO Year | 2018 | 2021 |
| Metric | VRCA | ZVIA |
|---|---|---|
| Price | $5.85 | $1.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $17.00 | $4.93 |
| AVG Volume (30 Days) | 29.4K | ★ 1.1M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.88 |
| EPS | N/A | ★ N/A |
| Revenue | $35,577,000.00 | ★ $161,259,000.00 |
| Revenue This Year | N/A | $8.30 |
| Revenue Next Year | $94.44 | $6.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 370.22 | 4.01 |
| 52 Week Low | $0.52 | $1.11 |
| 52 Week High | $9.82 | $3.66 |
| Indicator | VRCA | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 55.11 |
| Support Level | $5.32 | $1.13 |
| Resistance Level | $6.48 | $1.53 |
| Average True Range (ATR) | 0.48 | 0.12 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 8.33 | 69.74 |
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.